Janet M. Shapiro, MD, thought she had recovered from a mild COVID-19 illness and was ready to get back to work. It turned out, however, that the virus wasn’t done with her quite yet.  

Overall, the simulations inspired clinicians to change part of the treatment plan for 16 of 42 patients.  

The proposed changes, announced August 12, are focused on easing a variety of requirements.

Some researchers have shared concerns about how statin use may impact COVID-19 patients, but a new meta-analysis suggests there is a significant benefit. 

Researchers explored 43 years of data from the Framingham Heart Study.

The multicenter study tracked data from more than 1,600 patients in 11 different states.

Cardiac involvement and myocardial inflammation are common in recovered COVID-19 patients, according to a new study published in JAMA Cardiology.

In February and March 2020, the inevitable happened: COVID-19 came to the United States, hitting the country’s healthcare system like a 10-pound sledgehammer. 

As its techniques and technologies mature, medical AI will increasingly be used to predict the health trajectories of both outpatients and inpatients. But how will it do at converting educated projections into preventative care?

Scott Atlas, MD, is a senior fellow at Stanford University's Hoover Institution, and is serving as an advisor to the president on pandemic-related matters.